http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3973033-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6c17612db7d98bb4baf5d622f5250492 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-16 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-16 |
| filingDate | 1973-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1976-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e649141e55954f7dc1c82349f27ce68f |
| publicationDate | 1976-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-3973033-A |
| titleOfInvention | Compositions and methods for producing a vasodilatory effect with a naphthyl tetrahydrofurfuryl amino-ester |
| abstract | The present invention relates to substituted tetrahydrofurfuryl aminoesters. The novel tetrahydrofurfuryl dialkyl aminoesters are represented by the formula C2H5 R-CH2-CH-CO2CH2-CH2N ANGLE ¦ ¦C2H5 CH2 in which R is a member of the group formed by the 2-naphthyl, 2-naphthyl substituted in the 6-position with alkoxy and 5,6,7,8-tetrahydro-1-naphthyl radicals. The addition salts with the therapeutically acceptable acids, the starting and intermediate products of these aminoesters, also form the subject of the invention. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7121104-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006059934-A1 |
| priorityDate | 1971-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 156.